CICOIRA, Mariantonietta
 Distribuzione geografica
Continente #
NA - Nord America 3.629
EU - Europa 3.143
AS - Asia 659
SA - Sud America 8
OC - Oceania 7
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 7.453
Nazione #
US - Stati Uniti d'America 3.612
GB - Regno Unito 1.614
CN - Cina 592
FR - Francia 304
IE - Irlanda 241
FI - Finlandia 220
DE - Germania 207
SE - Svezia 202
IT - Italia 179
UA - Ucraina 97
BE - Belgio 34
VN - Vietnam 30
TR - Turchia 15
RU - Federazione Russa 14
CA - Canada 12
AU - Australia 6
IN - India 6
PH - Filippine 6
BR - Brasile 4
CZ - Repubblica Ceca 4
IR - Iran 4
NL - Olanda 4
DK - Danimarca 3
EG - Egitto 3
IL - Israele 3
JP - Giappone 3
MX - Messico 3
RO - Romania 3
AT - Austria 2
CH - Svizzera 2
CL - Cile 2
ES - Italia 2
EU - Europa 2
GR - Grecia 2
MD - Moldavia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BS - Bahamas 1
HU - Ungheria 1
IM - Isola di Man 1
LU - Lussemburgo 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PL - Polonia 1
ZA - Sudafrica 1
Totale 7.453
Città #
Southend 1.516
Jacksonville 809
Woodbridge 581
Chandler 509
Ann Arbor 333
Houston 253
Dublin 240
Ashburn 154
Lawrence 121
Princeton 121
Wilmington 98
Beijing 90
Nanjing 89
Verona 69
Sindelfingen 66
Jinan 62
Boardman 36
Brussels 34
Shenyang 34
Hebei 32
Tianjin 27
Changsha 26
Milan 24
Hangzhou 22
New York 22
Dong Ket 20
Norwalk 20
Helsinki 19
Nanchang 19
Taiyuan 18
Zhengzhou 18
Ningbo 16
Fairfield 14
Taizhou 14
Haikou 13
Jiaxing 13
Guangzhou 11
Düsseldorf 10
Fuzhou 9
Washington 9
Lancaster 8
Lanzhou 7
Seattle 7
Auburn Hills 6
Chicago 6
Falls Church 6
Toronto 6
Baguio City 5
Orchard Park 5
Redmond 5
Redwood City 5
Riva 5
Bologna 4
Edinburgh 4
Los Angeles 4
Monza 4
Novokuznetsk 4
Scottsdale 4
Augusta 3
Brno 3
Clearwater 3
Detroit 3
Dongguan 3
Ferrara 3
Mexico City 3
Qingdao 3
Ravenna 3
San Diego 3
San Mateo 3
Brescia 2
Cairo 2
Cambridge 2
Canberra 2
Des Moines 2
Hanover 2
London 2
Montreal 2
Mumbai 2
Rio de Janeiro 2
Sabz 2
San Francisco 2
St Petersburg 2
Stockholm 2
Vienna 2
Xiangfen 2
Zanjan 2
Zurich 2
Arbus 1
Athens 1
Auburn 1
Auckland 1
Bergamo 1
Berlin 1
Boston 1
Brembate 1
Brooklyn 1
Budapest 1
Buenos Aires 1
Buffalo 1
Callao 1
Totale 5.768
Nome #
Exercise tolerance can explain the obesity paradox in patients with systolic heart failure: data from the MECKI Score Research Group 657
Cardiorenal Syndrome Type 1: Pathophysiological Crosstalk Leading to Combined Heart and Kidney Dysfunction in the Setting of Acutely Decompensated Heart Failure. 129
Aortic and mitral annular calcification are predictive of all-cause and cardiovascular mortality in patients with type 2 diabetes. 111
Relationship between mitral regurgitation and myocardial viability after acute myocardial infarction: their impact on prognosis 101
Skeletal muscle mass independently predicts peak oxygen consumption and ventilatory response during exercise in noncachectic patients with chronic heart failure. 95
Aortic distensibility independently affects exercise tolerance in patients with dilated cardiomyopathy. 94
Alterazioni muscolari e intolleranza allo sforzo nello scompenso cardiaco congestizio: ruolo centrale della periferia 90
Increased aortic pulse wave velocity as measured by echocardiography is strongly associated with poor prognosis in patients with heart failure. 89
Role of growth hormone in chronic heart failure: therapeutic implications 87
Additional value of pulmonary vein parameters in defining pseudonormalization of mitral inflow pattern. 87
The role of angiotensin-converting enzyme polymorphism in congestive heart failure. 86
Echocardiographically Derived Pulse Wave Velocity and Diastolic Dysfunction Are Associated with an Increased Incidence of Atrial Fibrillation in Patients with Systolic Heart Failure 86
High tumour necrosis factor-alpha levels are associated with exercise intolerance and neurohormonal activation in chronic heart failure patients. 84
Predicting heart failure outcome from cardiac and comorbid conditions: The 3C-HF score. 81
Elevated serum uric acid levels are associated with diastolic dysfunction in patients with dilated cardiomyopathy. 80
Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure. 80
Left atrial overload can be used to estimate mitral regurgitant volume. 79
Chronic heart failure and cardiac cachexia and links between the endocrine and immune system 79
Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. 79
Aortic stiffness correlates with an increased extracellular matrix turnover in patients with dilated cardiomyopathy. 79
Left Atrial Volume Provides Independent and Incremental Information Compared With Exercise Tolerance Parameters in Patients With Heart Failure and Left Ventricular Systolic Dysfunction. 78
Carotid atherosclerotic plaque instability in patients with acute myocardial infarction. 76
Growth hormone resistance in chronic heart failure and its therapeutic implications. 76
Cardio-renal cachexia syndromes (CRCS): pathophysiological foundations of a vicious pathological circle. 75
Association of deranged adrenal steroid metabolism with anemia in chronic heart failure. 74
ESPEN Guidelines on Enteral Nutrition: Cardiology and pulmonology. 74
Statin use and survival in patients with chronic heart failure--results from two observational studies with 5200 patients 73
Inhibitors of angiotensin-converting enzyme and physical function in older women. 73
Growth hormone treatment in chronic heart failure: lessons from the first 99 patients 72
Biventricular pacing. 72
Chronic heart failure with preserved left ventricular ejection fraction: Diagnostic and prognostic value of left atrial size. 71
Body mass index, prognosis and mode of death in chronic heart failure: Results from the Valsartan Heart Failure Trial. 71
Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy. 70
Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia 69
Statin use and survival in patients with chronic heart failure--results from two observational studies with 5200 patients. 69
Aortic distensibility independently affects exercise tolerance in patients with dilated cardiomyopathy 69
Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype 68
Impact of body mass index on short-term outcome after acute myocardial infarction: does excess body weight have a paradoxical protective role? 68
Echocardiographic determinants of mortality in patients 67 years of age with chronic heart failure 67
Role of growth hormone in chronic heart failure 66
Determinants and prognostic value of left atrial volume in patients with dilated cardiomyopathy. 66
Independent and additional prognostic value of aminoterminal propeptide of type III procollagen circulating levels in patients with chronic heart failure. 65
Prognostic value of detection of myocardial viability using low-dose dobutamine echocardiography in infarcted patients 65
Prognostic implications of evaluation of contractile reserve in akinetic and hypokinetic segments during low dose dobutamine echocardiography in patients with acute myocardial infarction. 65
Amino-terminal propeptide of type III procollagen is associated with restrictive mitral filling pattern in patients with dilated cardiomyopathy: a possible link between diastolic dysfunction and prognosis. 65
Association of aortic valve sclerosis and coronary artery disease in patients with severe nonischemic mitral regurgitation. 65
Chronic heart failure in the very elderly: clinical status, survival and prognostic factors in 188 patients more than 70 years old 63
Identification of High-Risk Chronic Heart Failure Patients in Clinical Practice: Role of Changes in Left Ventricular Function. 63
Clinical characteristics and survival of patients with chronic heart failure and prolonged QRS duration 62
A higher body mass index is associated with reduced prevalence of unstable atherosclerotic plaque: A possible explanation of the obesity paradox. 62
Functional mitral regurgitation in patients with aortic stenosis: prevalence, clinical correlates and pathophysiological determinants: a quantitative prospective study. 62
Renal arterial pulsatility predicts progression of chronic kidney disease in chronic heart failure patients. 62
Deceptive meaning of oxygen uptake measured at the anaerobic threshold in patients with systolic heart failure and atrial fibrillation. 61
Enhanced prognostic value from cardiopulmonary exercise testing in chronic heart failure by non-linear analysis: oxygen uptake efficiency slope. 61
Uric acid and survival in chronic heart failure: validation and application in metabolic, functional and hemodynamic staging. 60
Aortic valve sclerosis: a marker of significant obstructive coronary artery disease in patients with chest pain? 60
Beta-blockers can improve survival in medically-treated patients with severe symptomatic aortic stenosis 60
Prediction of mortality in chronic heart failure from peak oxygen consumption adjusted for either body weight or lean tissue. 59
Fill in the Gaps of Secondary Mitral Regurgitation: a Continuum Challenge From Pathophysiology to Prognosis 59
Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not norepinephrine or TNF-alpha 58
Mitral regurgitation and left ventricular diastolic dysfunction similarly affect mitral and pulmonary vein flow Doppler parameters: the advantage of end-diastolic markers. 57
Myocardial viability independently influences left ventricular diastolic function in the early phase after acute myocardial infarction. 57
Aortic valve sclerosis is a marker of atherosclerosis independently of traditional clinical risk factors. Analysis in 712 patients without ischemic heart disease. 57
Effects of ace gene insertion/deletion polymorphism on response to spironolactone in patients with chronic hearth failure. 56
Relation of aldosterone "escape" despite angiotensin-converting enzyme inhibitor administration to impaired exercise capacity in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. 56
Exercise Performance Is a Prognostic Indicator in Elderly Patients With Chronic Heart Failure--Application of Metabolic Exercise Cardiac Kidney Indexes Score 54
Heart failure in women treated with adjuvant trastuzumab fro breast cancer. 52
Reduced glucose transporter GLUT4 in skeletal muscle predicts insulin resistance in non-diabetic chronic heart failure patients independently of body composition. 51
Prognostic relevance of pulmonary arterial compliance in patients with chronic heart failure. 51
Emerging strategies for chronic heart failure: the role of gene therapy 50
Identification of chronic heart failure patients with a high 12-month mortality risk using biomarkers including plasma C-terminal pro-endothelin-1. 49
Effects on survival of loop diuretic dosing in ambulatory patients with chronic heart failure using a propensity score analysis 49
Outpatients electrical cardioversion of atrial fibrillation: 8 years' experience. Analysis of shock-related arrhythmias. 49
Secretory sphingomyelinase is upregulated in chronic heart failure: a second messenger system of immune activation relates to body composition, muscular functional capacity, and peripheral blood flow. 48
Long-term prognostic value of the stenosis of the infarct-related artery and the presence of viable myocardium in akinetic ventricular regions in infarcted patients 47
Prognostic role of atrial fibrillation in patients affected by chronic heart failure. Data from the MECKI score research group 47
Mineralocorticoid receptor antagonists for heart failure: a real-life observational study 47
Echocardiographic advances in hypertrophic cardiomyopathy: Three-dimensional and strain imaging echocardiography 47
Mitral regurgitation, left atrial structural and functional remodelling and the effect on pulmonary haemodynamics 47
Sex Profile and Risk Assessment With Cardiopulmonary Exercise Testing in Heart Failure: Propensity Score Matching for Sex Selection Bias 46
Ambient air pollution as a new risk factor for cardiovascular diseases: Time to take action 45
Role of iron deficiency and anemia in cardio-renal syndromes. 44
Aortic stiffness: an old concept for new insights into the pathophysiology of functional mitral regurgitation. 44
Prognostic relevance of a non-invasive evaluation of right ventricular function and pulmonary artery pressure in patients with chronic heart failure. 44
Relevance of Functional Mitral Regurgitation in Aortic Valve Stenosis 44
Determinants of exercise intolerance symptoms considered non-specific for heart failure in patients with stage A and B: role of the left atrium in the transition phase to overt heart failure 44
null 43
Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure. 42
Elevated serum uric acid levels are associated with diastolic dysfunction in patients with dilated cardiomyopathy. 42
Severe acute left ventricular dysfunction in multiple sclerosis: a case report and review of the literature. 42
Myocardial infarction in a young patient with a previous history of repeated thrombophlebitis: combination of factor V Leiden and prothrombin G20210A gene polymorphisms with coronary artery disease. 42
Reduced glucose transporter GLUT4 in skeletal muscle predicts insulin resistance in non-diabetic chronic heart failure patients independently of body composition. 42
Mitral and aortic valve sclerosis/calcification and carotid atherosclerosis: results from 1065 patients. 42
Heart failure and anemia: Effects on prognostic variables 42
Ischemic etiology of heart failure identifies patients with more severely impaired exercise capacity. 41
Obesity paradox in patients with aortic valve stenosis. Protective effect of body mass index independently of age, disease severity, treatment modality and non-cardiac comorbidities. 41
Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction 41
Mitral regurgitation and dyspnoea: The expanding role of mitral effective regurgitant orifice among un-selected patients 41
Progression of Left Ventricular Dysfunction and Remodelling under Optimal Medical Therapy in CHF Patients: Role of Individual Genetic Background. 40
Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure 40
Totale 6.890
Categoria #
all - tutte 21.843
article - articoli 21.843
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.686


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019122 0 0 0 0 0 0 0 38 26 15 16 27
2019/20201.127 152 26 19 94 99 120 131 117 49 144 50 126
2020/20211.032 60 176 38 101 123 121 19 95 89 25 130 55
2021/2022723 78 191 18 29 17 28 10 46 23 30 66 187
2022/20231.600 143 119 192 254 156 359 16 121 157 13 48 22
2023/2024512 25 84 59 113 107 71 17 36 0 0 0 0
Totale 7.572